Compass Therapeutics, Inc.
CMPXNasdaqCIK 1738021HealthcareFiscal year ends Dec 31
Reports and events: 112 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-0412:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001171843-23-002868 |
| 2023-05-0412:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-002866 |
| 2023-04-2720:19 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001140361-23-020957 |
| 2023-04-2420:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-23-002480 |
| 2023-03-1512:15 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001171843-23-001691 |
| 2023-03-1016:56 ET | 8-K | 7.01 Regulation FD disclosure | 0001171843-23-001585 |
| 2023-02-2421:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-23-001157 |
| 2023-02-1021:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-23-000899 |
| 2023-01-1922:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-23-000338 |
| 2022-11-2921:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-22-007714 |
| 2022-11-1400:07 ET | SC 13D | Ownership report, active investor | 0001193125-22-282853 |
| 2022-11-1021:25 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-22-001162 |
| 2022-11-0914:00 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001171843-22-007269 |
| 2022-11-0221:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-22-007012 |
| 2022-08-1920:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001171843-22-005763 |
| 2022-08-0112:20 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-22-207806 |
| 2022-08-0112:01 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001171843-22-005187 |
| 2022-05-3117:41 ET | 8-K | 5.07 Shareholder vote results | 0001171843-22-004019 |
| 2022-05-0911:58 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-008244 |
| 2022-05-0411:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-22-003159 |
| 2022-04-2817:30 ET | DEF 14A | Proxy statementPeriod 2022-05-24 | 0001140361-22-016447 |
| 2022-04-2612:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-22-002790 |
| 2022-03-1820:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-004156 |
| 2022-02-2522:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-054600 |
| 2022-01-2013:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-22-000369 |
| 2021-12-2122:07 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-21-005307 |
| 2021-11-1213:24 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000950170-21-004267 |
| 2021-11-0922:30 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-21-001157 |
| 2021-11-0321:29 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-21-002863 |
| 2021-11-0120:05 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-21-002562 |
| 2021-10-0816:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-21-002075 |
| 2021-08-1618:32 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000950170-21-001486 |
| 2021-08-0523:20 ET | 8-K/A | 9.01 Financial statements and exhibits | 0000950170-21-000831 |
| 2021-07-1421:08 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-21-000771 |
| 2021-06-3017:42 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-21-000411 |
| 2021-06-0411:57 ET | 8-K | 5.07 Shareholder vote results | 0001193125-21-182106 |
| 2021-05-1318:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-027411 |
| 2021-04-3017:52 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001564590-21-022412 |
| 2021-04-2918:54 ET | DEF 14A | Proxy statementPeriod 2021-06-03 | 0001564590-21-021853 |
| 2021-04-1920:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001564590-21-019394 |
| 2021-03-0513:28 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001564590-21-011110 |
| 2020-12-1722:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001564590-20-057477 |
| 2020-11-0913:01 ET | S-1/A | Registration statement, amended | 0001193125-20-288526 |
| 2020-11-0912:31 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001564590-20-052190 |
| 2020-10-1914:31 ET | S-1 | Registration statement | 0001193125-20-271775 |
| 2020-09-1821:21 ET | S-1/A | Registration statement, amended | 0001193125-20-249227 |
| 2020-09-1514:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-20-245916 |
| 2020-08-1318:57 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001564590-20-039951 |
| 2020-08-1120:02 ET | S-1 | Registration statement | 0001193125-20-216242 |
| 2020-07-3121:26 ET | 8-K/A | 2.01 Completion of an acquisition or disposition | 0001213900-20-019701 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.